The Utility of pancreatic cyst fluid (PCF) glucose levels in the diagnosis of suspected mucinous pancreatic lesions
Endoscopy · 01.04.2023 · 55 (S 02 S 02) · S231
DOI: 10.1055/s-0043-1765618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2023. Verfasst von M. Shibeika und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
To identify the role of PCF glucose as an adjunct to carcinoembryonic antigen (CEA) in differentiating mucinous and non-mucinous cystic lesions, especially those with an indeterminate PCF CEA level (5–192 ug/l), given the variable sensitivity and specificity of CEA in isolation.
Methods
This prospective study included patients identified by the Regional HPB MDT requiring EUS and PCF analysis between October 2021 and November 2022. Samples were obtained through EUS-guided aspiration and analysed for glucose, CEA, lipase, mucin stain, and cytology.
Results
28 patients with pancreatic cysts underwent EUS/FNA, diagnosis was reached at MDT based on clinical presentation, biochemistry, cytology, and radiology: 13 IPMNs: 5 mucinous cystic neoplasms (MCNs): 6 pseudocysts: 3 serous cystic neoplasms (SCNs): 1 uncertain. All 9 mucinous lesions had glucose levels 192 ug/l in 8/14 (57%) mucinous lesions (4 excluded as samples not processed). One pseudocyst had a high CEA level. CEA had 57% sensitivity, 89% specificity, and 70% accuracy. 9/18 mucinous lesions had both glucose and CEA; 5/9 (55.5%) had low glucose with indeterminate CEA.
Conclusions
This, albeit small, series has illustrated the utility and superiority of intracystic glucose levels in conjunction with CEA levels when diagnosing mucinous lesions. As an inexpensive and simple test, it should complement CEA to avoid unnecessary discharge from surveillance. Publication History Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Shibeika, M., Iqbal, J., Farid, S., Lekharaju, V., & Mahmood, S. (2023). The Utility of pancreatic cyst fluid (PCF) glucose levels in the diagnosis of suspected mucinous pancreatic lesions. Endoscopy, 55(S 02 S 02), S231. https://doi.org/10.1055/s-0043-1765618
Vancouver
Shibeika M, Iqbal J, Farid S, Lekharaju V, Mahmood S. The Utility of pancreatic cyst fluid (PCF) glucose levels in the diagnosis of suspected mucinous pancreatic lesions. Endoscopy. 2023;55(S 02 S 02):S231. doi:10.1055/s-0043-1765618
BibTeX
@article{Shibeika2023,
author = {Shibeika, M. and Iqbal, J. and Farid, S. and Lekharaju, V. and Mahmood, S.},
title = {The Utility of pancreatic cyst fluid (PCF) glucose levels in the diagnosis of suspected mucinous pancreatic lesions},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {S 02 S 02},
pages = {S231},
doi = {10.1055/s-0043-1765618}
}
EUVIMED